NeoChord Investors

27 investors on Angel Roster list NeoChord in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and China.

Investors are matched on the company name in their portfolio, so companies that share the name NeoChord can appear together.

Investors listed
27
With verified email
52%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 27 NeoChord investors

The most complete profiles first. Showing 27 of 27.

  • Adam GreeneVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Andrew FergusonVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Michael HolgateVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Narendra NayakVerified

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nicholas BishopVerified

    Hedge Fund, Venture Capital, Investment Partner · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Nina EssandohVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareHospitalsE-commerceAccounting

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Andy TseVerified

    Venture Capital · China

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Brian McGregorVerified

    Venture Capital · United States

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Howie FurstVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Jon RootVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Kevin BergVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Rick LewisVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 61 more

    Verified email available

  • Steve KrauszVerified

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 66 more

    Verified email available

  • Vincent MelletVerified

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Verified email available

  • Aidan Elliott

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedPre-SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Jacques Benkoski

    Venture Capital, Strategy Operator, CEO · United States

    Series AHealth CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • James Benfield

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • James Flynn

    Hedge Fund, Venture Capital, Investor · United States

    Series BHealth CareInvestment ManagementArtificial Intelligence (AI)Information Services

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 80 more

    Contact details available

  • Rob Ospalik

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Avi Kometz

    Hedge Fund, Investment Partner · United States

    Health CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)

    Portfolio: RubiconMD, Four Points Innovation, AveXis, CathWorks and 76 more

    Contact details available

  • Dafina Toncheva

    Venture Capital · United States

    Health CareCybersecurityWomen FoundedEnterprise Software

    Portfolio: Livefyre, Edgewise Therapeutics, HighLife, ZypMedia and 64 more

    Contact details available

  • Greg MaurerVerified

    Venture Capital · United States

    Health CareEnterprise SoftwareDentalTechNetwork Hardware

    Portfolio: Scale Computing, Celleration, BioSET, NeoChord and 3 more

    Verified email available

  • Huaming Gu

    Venture Capital · China

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Jerry Callahan

    Venture Capital, Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesInformation Technology (IT)

    Portfolio: Nymirum, Trapelo Health, Cirius Therapeutics, Metabolic Solutions Development and 6 more

    Contact details available

  • Mark Olesnavage

    Venture Capital, Private Equity Firm · United States

    Health CareLife ScienceInformation ServicesInformation Technology (IT)

    Portfolio: Nymirum, Trapelo Health, Cirius Therapeutics, Metabolic Solutions Development and 6 more

    Contact details available

  • Michael Fulton, M.D.

    Venture Capital, Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Services

    Portfolio: Nymirum, Trapelo Health, Cirius Therapeutics, Metabolic Solutions Development and 6 more

    Contact details available

  • Kevin Etzkorn

    Venture Capital · United States

    Health CareEnterprise SoftwareDentalTechNetwork Hardware

    Portfolio: Scale Computing, Celleration, BioSET, NeoChord and 3 more

    Contact details available

Frequently asked questions

How many NeoChord investors are on Angel Roster?

Angel Roster lists 27 NeoChord investors. 14 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (23), Private Equity Firms (8) and Hedge Funds (8). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do NeoChord investors invest in?

Among those that list a stage, the most common are Seed (6), Series B (4) and Pre-Seed (1).

Where are NeoChord investors based?

Most are based in the United States (21), the United Kingdom (4) and China (2).

Which companies have NeoChord investors backed?

The most-backed portfolio companies among them are SentreHEART (13), Celleration (11), Signal (9), Integrated Diagnostics (9) and MI Bioresearch (9).

How do I contact NeoChord investors?

Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.